Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bortezomib in the treatment of AL amyloidosis: targeted therapy?

× No keyword cloud information.

24 in total

Review 1. Amyloidosis and POEMS syndrome.

Authors: Cheng E Chee; Angela Dispenzieri; Morie A Gertz
Journal: Expert Opin Pharmacother Date: 2010-06 Impact factor: 3.889

Review 2. New insights and modern treatment of AL amyloidosis.

Authors: Chakra P Chaulagain; Raymond L Comenzo
Journal: Curr Hematol Malig Rep Date: 2013-12 Impact factor: 3.952

3. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.

Authors: Lauren Gray Gilstrap; Emily Niehaus; Rajeev Malhotra; Van-Khue Ton; James Watts; David C Seldin; Joren C Madsen; Marc J Semigran
Journal: J Heart Lung Transplant Date: 2013-11-05 Impact factor: 10.247

4. The Effect and Safety of Bortezomib in the Treatment of AL Amyloidosis: A Systematic Review and Meta-Analysis.

Authors: Fengjuan Jiang; Jin Chen; Hui Liu; Lijuan Li; Wenli Lu; Rong Fu
Journal: Indian J Hematol Blood Transfus Date: 2018-03-07 Impact factor: 0.900

5. Current treatment of AL amyloidosis.

Authors: Giovanni Palladini; Giampaolo Merlini
Journal: Haematologica Date: 2009-08 Impact factor: 9.941

6. Therapeutic landscape of carfilzomib and other modulators of the ubiquitin-proteasome pathway.

Authors: Constantine S Mitsiades
Journal: J Clin Oncol Date: 2015-01-20 Impact factor: 44.544

7. Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis.

Authors: Donna E Reece; Ute Hegenbart; Vaishali Sanchorawala; Giampaolo Merlini; Giovanni Palladini; Joan Bladé; Jean-Paul Fermand; Hani Hassoun; Leonard Heffner; Vishal Kukreti; Robert A Vescio; Lixia Pei; Christopher Enny; Dixie-Lee Esseltine; Helgi van de Velde; Andrew Cakana; Raymond L Comenzo
Journal: Blood Date: 2014-09-08 Impact factor: 22.113

Review 8. Amyloidosis: pathogenesis and new therapeutic options.

Authors: Giampaolo Merlini; David C Seldin; Morie A Gertz
Journal: J Clin Oncol Date: 2011-04-11 Impact factor: 44.544

Review 9. Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.

Authors: Q Ping Dou; Jeffrey A Zonder
Journal: Curr Cancer Drug Targets Date: 2014 Impact factor: 3.428

10. Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias.

Authors: Aldo M Roccaro; Irene M Ghobrial; Simona Blotta; Steven P Treon; Michele Malagola; Kenneth C Anderson; Paul G Richardson; Domenico Russo
Journal: Biologics Date: 2008-09